Literature DB >> 23105429

Early detection of prostate cancer: evaluating the diagnostic performance of prostate specific antigen by comparing with histological technique among africans.

M A Emokpae1, S C Das, T Orok, A Z Mohammed, S A Hassan.   

Abstract

This study was conducted to investigate the diagnostic performance characteristics of prostate specific antigen (PSA) by comparing serum PSA value with histological findings in patients suspevted of having prostate cancer in Aminu Kano Teaching Hospital. Nigeria. Clinical and Laboratory records were examined and collated for serum PSA values, together with histological findings of biopsy specimen, clinical diagnosis, age of patients, and mode of presentation. The serum PSA values were determined by ELECSYS 1010 autoanalysers Roche, Germany based on electrochemiluminescence immunoassay technique. The results show that serum PSA values increase with age in the assymptomatic non-cancer patients who came for medical check up but were within normal limit. In prostatic disease conditions PSA values were raised in benign prostatic hyperplasia 35.957± 4.0315ng/ml, in undifferentiated carcinoma 56.22±4.295ng/ml and adenocarcinoma >100ng/ml as compared to the normal range (0-4ng/ml). These cases were confirmed by histological diagnosis. It is concluded that PSA evaluations is a sensitive marker for prostate cancer but because of various other conditions that affect serum PSA concentration, other methods of investigations such as Digital Rectal examination, Trans Urethral Ultra-Sonography and histological examination should be combined to confirm diagnosis. Prognosis of patients will be better if early diagnosis is made.

Entities:  

Keywords:  Africans; Prostate specific antigen

Year:  2004        PMID: 23105429      PMCID: PMC3453910          DOI: 10.1007/BF02872392

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  8 in total

Review 1.  Diagnosis and treatment of urological malignancy: the prostate.

Authors:  A P Doherty; T J Christmas
Journal:  Br J Hosp Med       Date:  1996 Feb 7-20

2.  Cancer statistics, 1993.

Authors:  C C Boring; T S Squires; T Tong
Journal:  CA Cancer J Clin       Date:  1993 Jan-Feb       Impact factor: 508.702

3.  Benign prostatic hyperplasia and prostate carcinoma in native Africans.

Authors:  D Dawam; A H Rafindadi; G D Kalayi
Journal:  BJU Int       Date:  2000-06       Impact factor: 5.588

Review 4.  Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.

Authors:  J E Oesterling
Journal:  J Urol       Date:  1991-05       Impact factor: 7.450

5.  Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer.

Authors:  A Christensson; T Björk; O Nilsson; U Dahlén; M T Matikainen; A T Cockett; P A Abrahamsson; H Lilja
Journal:  J Urol       Date:  1993-07       Impact factor: 7.450

6.  Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.

Authors:  J E Oesterling; S J Jacobsen; C G Chute; H A Guess; C J Girman; L A Panser; M M Lieber
Journal:  JAMA       Date:  1993-08-18       Impact factor: 56.272

7.  Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years.

Authors:  A W Partin; C R Pound; J Q Clemens; J I Epstein; P C Walsh
Journal:  Urol Clin North Am       Date:  1993-11       Impact factor: 2.241

8.  Clinical behavior of prostatic specific antigen and prostatic acid phosphatase: a comparative study.

Authors:  J Morote Robles; A Ruibal Morell; J Palou Redorta; J A de Torres Mateos; A Soler Roselló
Journal:  Eur Urol       Date:  1988       Impact factor: 20.096

  8 in total
  2 in total

1.  Simultaneous determination of free and total prostate-specific antigen by a magnetic particle-based time-resolved fluoroimmunoassay.

Authors:  Bin Zhou; Jue Zhang; Zhongwei Lv; Jun Fan; Yi Zhang; Biao Huang
Journal:  J Clin Lab Anal       Date:  2017-01-19       Impact factor: 2.352

2.  Emergent trends in the reported incidence of prostate cancer in Nigeria.

Authors:  Godwin O Ifere; Fisseha Abebe; Godwin A Ananaba
Journal:  Clin Epidemiol       Date:  2012-01-10       Impact factor: 4.790

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.